has role has attribute value has attribute mutagen oxaliplatin (SP-4-2)[(1R,2R)-cyclohexane-1,2-diamine-kappa(2)N,N'][ethanedioato(2-)-kappa(2)O(1),O(2)]platinum (SP-4-2-(1R-trans))-(1,2-cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')platinum A platinum coordination entity that is a commonly used chemothrepeutic drug for treatment of colorectal cancer. CAS:61825-94-3 CAS:63121-00-6 CHEBI:31941 DrugBank:DB00526 Eloxatin Gmelin:1046012 Gmelin:28892 LINCS:LSM-6352 Oxaliplatin PMID:11300320 PMID:14755010 PMID:15477639 PMID:17347561 PMID:18440088 PMID:19138416 PMID:19735649 PMID:27756654 PMID:28186109 PMID:28398406 PMID:28415810 PMID:28499428 PMID:28505615 PMID:28624791 PMID:28642473 PMID:28654098 PMID:28695397 PMID:28762171 PMID:28777427 PMID:28800641 PMID:28811232 PMID:28812173 PMID:28837658 PMID:28876454 PMID:28881354 PMID:28881481 PMID:28884286 PMID:28894576 PMID:28924870 PMID:28938919 Reaxys:15700099 oxalato(1,2-diaminocyclohexane)platinum(II) oxaliplatin oxaliplatine oxaliplatino oxaliplatinum antineoplastic agent organic molecular entity drug liver toxicity Most-DILI-Concern